What makes a P450 tick?

Trends in Biochemical Sciences

Volumn 38, Issue 3, 2013, Pages 140-150

  Munro, Andrew W ^a   Girvan, Hazel M ^a   Mason, Amy E ^a   Dunford, Adrian J ^a   McLean, Kirsty J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HEME OXYGENASE; STEROL 14ALPHA DEMETHYLASE;

BINDING AFFINITY; BIOTECHNOLOGY; CATALYSIS; CELL TRANSFORMATION; DEAMINATION; DECARBOXYLATION; ELECTRON NUCLEAR DOUBLE RESONANCE; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; ENZYME SYNTHESIS; EPOXIDATION; HUMAN; HYDROXYLATION; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; OXIDATION; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; REVIEW; STEREOCHEMISTRY;

ANIMALS; BIOCATALYSIS; BIOMEDICAL TECHNOLOGY; BIOTECHNOLOGY; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS;

IXODIDA; MAMMALIA;

EID: 84874252277     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2012.11.006     Document Type: Review

References (100)

1. Munro A.W., et al. Variations on a (t)heme: novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. Nat. Prod. Rep. 2007, 24:585-609.
2. Omura T., Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 1964, 239:2370-2378.
3. Torres Pazmiňo D.E., et al. Monooxygenases as biocatalysts: classification, mechanistic aspects and biotechnological applications. J. Biotechnol. 2010, 146:9-24.
4. Tinberg C.E., Lippard S.J. Dioxygen activation in soluble methane monooxygenase. Acc. Chem. Res. 2011, 44:280-288.
5. Guengerich F.P. Mechanisms of cytochrome P450 substrate oxidation. J. Biochem. Mol. Toxicol. 2007, 21:163-168.
6. Mast N., et al. Structural basis for three step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J. Biol. Chem. 2011, 286:5607-5613.
7. 5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency. J. Clin. Endocrinol. Metab. 2012, 97:E465-E475.
8. Hershkovitz E., et al. Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J. Clin. Endocrinol. Metab. 2008, 93:3584-3588.
9. Guengerich F.P. Human cytochrome P450 enzymes. Cytochrome P450: Structure, Mechanism and Biochemistry 2005, 377-530. Kluwer Academic. 3rd edn. P.R. Ortiz de Montellano (Ed.).
10. Crettol S., et al. Pharmacogenetics of phase I and phase II drug metabolism. Curr. Pharm. Des. 2010, 16:204-219.
11. Isin E.M., Guengerich F.P. Complex reactions catalyzed by cytochrome P450 enzymes. Biochim. Biophys. Acta 2007, 1770:314-329.
12. Bernhardt R. Cytochromes P450 as versatile biocatalysts. J. Biotechnol. 2006, 124:128-145.
13. Lepesheva G.I., Waterman M. Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim. Biophys. Acta 2007, 1770:467-477.
14. Daiber A., et al. Nitric oxide reductase (P450nor) from Fusarium oxysporum. J. Inorg. Biochem. 2005, 99:185-193.
15. Li L., et al. Modes of heme binding and substrate access for cytochrome P450 CYP74A revealed by crystal structures of allene oxide synthase. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13883-13888.
16. McLean K.J., et al. Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes. Biochem. Soc. Trans. 2012, 40:587-593.
17. Honda A., et al. Cholesterol 25-hydroxylation activity of CYP3A. J. Lipid Res. 2011, 52:1509-1516.
18. Poulos T.L., et al. High-resolution structure of cytochrome P450cam. J. Mol. Biol. 1987, 195:687-700.
19. SCC, cholesterol desmolase. J. Biochem. 1987, 101:879-887.
20. Leys D., et al. Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06Å reveals novel features of cytochrome P450. J. Biol. Chem. 2003, 278:5141-5147.
21. Smith B.D., et al. Structure of the human lung cytochrome P450 2A13. J. Biol. Chem. 2007, 282:17306-17313.
22. Auclair K., et al. Roles of the proximal heme thiolate ligand in cytochrome P450cam. J. Am. Chem. Soc. 2001, 123:4877-4885.
23. Ogliaro F., et al. The 'push' effect of the thiolate ligand in cytochrome P450: a theoretical gauging. J. Inorg. Biochem. 2002, 91:554-567.
24. Zhang H., et al. Targeting of the highly conserved threonine 302 residue of cytochromes P450 2B family during mechanism-based inactivation by aryl acetylenes. Arch. Biochem. Biophys. 2011, 507:135-143.
25. Sligar S.G. Coupling of spin, substrate and redox equilibria in cytochrome P450. Biochemistry 1976, 15:5399-5406.
26. Daff S.N., et al. Redox control of the catalytic cycle of flavocytochrome P-450 BM3. Biochemistry 1997, 36:13816-13823.
27. Groves J.T. High-valent iron in chemical and biological oxidations. J. Inorg. Biochem. 2006, 100:434-437.
28. Davydov R., Hoffman B.M. Active intermediates in heme mono reactions as revealed by cryoreduction/annealing, EPR/ENDOR studies. Arch. Biochem. Biophys. 2011, 507:36-43.
29. Schlichting I., et al. The catalytic pathway of cytochrome P450cam at atomic resolution. Science 2000, 287:1615-1622.
30. Sivaramakrishnan S., et al. A novel intermediate in the reaction of seleno CYP119 with m-chlorobenzoic acid. Biochemistry 2011, 50:3014-3024.
31. Rittle J., Green M.T. Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics. Science 2010, 330:933-937.
32. Williams P.A., et al. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol. Cell 2000, 5:121-131.
33. Johnson E.F., et al. The structure of microsomal cytochrome P450 2C5: a steroid and drug metabolizing enzyme. Endocr. Res. 2002, 28:435-441.
34. Poulos T.L., Johnson E.F. Structures of cytochrome P450 enzymes. Cytochrome P450: Structure, Mechanism and Biochemistry 2005, 87-114. Kluwer Academic. 3rd edn. P.R. Ortiz de Montellano (Ed.).
35. Poulos T.L., et al. Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. Biochemistry 1986, 25:5314-5322.
36. Ravichandran K.G., et al. Crystal structure of hemoprotein domain of P450 BM-3. A prototype for microsomal P450s. Science 1993, 261:731-736.
37. Cupp-Vickery J.R., Poulos T.L. Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat. Struct. Biol. 1995, 2:144-153.
38. Yano J.K., et al. Crystal structure of a thermophilic cytochrome P450 from the archaeon Sulfolobus solfataricus. J. Biol. Chem. 2000, 275:31086-31092.
39. Schuler M.A., Sligar S.G. Diversities and differences in P450 systems: an introduction. Metal Ions in Life Sciences 2007, Vol. 3:1-26. Wiley.
40. Cojocaru V., et al. The ins and outs of cytochrome P450s. Biochim. Biophys. Acta 2007, 1770:390-401.
41. Denisov I.G., et al. Structural differences between soluble and membrane bound cytochrome P450s. J. Inorg. Biochem. 2012, 108:150-158.
42. Munro A.W., et al. Cytochrome P450-redox partner fusion enzymes. Biochim. Biophys. Acta 2007, 1770:345-359.
43. Wang M., et al. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8411-8416.
44. 5. Arch. Biochem. Biophys. 2011, 507:144-153.
45. Akhtar M., et al. A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17). J. Steroid Biochem. Mol. Biol. 2011, 125:2-12.
46. 5 directly induces positive cooperativity. Arch. Biochem. Biophys. 2005, 438:21-28.
47. 5 on CYP3A4 activity and stability in vivo. Arch. Biochem. Biophys. 1999, 366:116-124.
48. 5 rules uncoupling mechanisms. Biochemistry 1998, 37:11412-11424.
49. 5 with flavocytochrome P450 BM3 and its domains. Drug Metab. Rev. 2007, 39:599-617.
50. 5. J. Biol. Chem. 2008, 283:31385-31393.
51. 5 profoundly affects hepatic and extrahepatic drug metabolism. Mol. Pharmacol. 2010, 78:269-278.
52. Whitehouse C.J., et al. P450 BM3 (CYP102A1): connecting the dots. Chem. Soc. Rev. 2011, 41:1218-1260.
53. Munro A.W., et al. P450 BM3: the very model of a modern flavocytochrome. Trends Biochem. Sci. 2002, 27:250-257.
54. Jackson C.J., et al. A novel sterol 14α-demethylase/ferredoxin fusion protein (MCCYP51FX) from Methylococcus capsulatus represents a new class of the cytochrome P450 superfamily. J. Biol. Chem. 2002, 277:46959-46965.
55. Rylott E.L., et al. The explosive-degrading cytochrome P450XplA: biochemistry, structural features and prospects for bioremediation. Biochim. Biophys. Acta 2011, 1814:230-236.
56. Warman A.J., et al. Characterization of Cupriavidus metallidurans CYP116B1 - a thiocarbamate herbicide oxygenating P450-phthalate dioxygenase reductase fusion protein. FEBS J. 2012, 279:1675-1693.
57. Shoun H., et al. Fungal denitrification and nitric oxide reductase cytochrome P450nor. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:1186-1194.
58. Song W.-C., et al. Molecular cloning of an allene oxide synthase: A cytochrome P450 specialized for the metabolism of fatty acid hydroperoxides. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8519-8523.
59. 2-dependent cytochrome P450SPα with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. J. Biol. Chem. 2011, 286:29941-29950.
60. Rude M.A., et al. Terminal olefin (1-alkene) biosynthesis by a novel P450 fatty acid decarboxylase. Appl. Environ. Microbiol. 2011, 77:1718-1727.
61. Koch C., et al. Linoleic acid positioning in psi factor producing oxygenase A, a fusion protein with an atypical cytochrome P450 activity. FEBS J. 2012, 279:1594-1606.
62. Sakaki T. Practical application of cytochrome P450. Biol. Pharm. Bull. 2012, 35:844-849.
63. Watanabe I., et al. Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor. Gene 1995, 163:81-85.
64. Hans M., et al. Engineering of an Amycolatopsis orientalis P450 compacting hydroxylase into a pravastatin synthase by changing the stereospecificity of the enzyme. Practical Methods for Biocatalysis and Biotransformations 2 2012, 130-133. Wiley.
65. Ro D.K., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006, 440:940-943.
66. Westfall P.J., et al. Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E111-E118.
67. Szczebara F.M., et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat. Biotechnol. 2003, 21:143-149.
68. Hannemann F., et al. Design of an Escherichia coli system for the whole cell mediated steroid synthesis and molecular evolution of steroid hydroxylase. J. Biotechnol. 2006, 124:172-181.
69. Katsumoto Y., et al. Engineering of the rose flavonoid biosynthetic pathway successfully generated blue-hued flowers accumulating delphinidin. Plant Cell Physiol. 2007, 48:1589-1600.
70. Denisov I.G., Sligar S.G. Cytochromes P450 in nanodiscs. Biochim. Biophys. Acta 2011, 1814:223-229.
71. Perera R., et al. Neutral thiol as a proximal ligand to ferrous heme iron: implications for heme proteins that lose cysteine thiolate ligation on reduction. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3641-3646.
72. Dunford A.J., et al. Rapid heme iron reduction by laser photoexcitation of Mycobacterium tuberculosis CYP121 and CYP51B1. Analysis of CO complexation reactions and reversibility of the P450/P420 equilibrium. J. Biol. Chem. 2007, 282:24816-24824.
73. Ogura H., et al. EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B.Substrate-mediated rescue of a P450 enzyme. Biochemistry 2004, 43:14712-14721.
74. Driscoll M.D., et al. Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen. J. Biol. Chem. 2010, 285:38270-38282.
75. Urlacher V.B., Girhard M. Cytochrome P450 monooxygenases: an update on perspectives for synthetic application. Trends Biotechnol. 2012, 30:26-36.
76. Glieder A., et al. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Nat. Biotechnol. 2002, 20:1135-1139.
77. Kille S., et al. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution. Nat. Chem. 2011, 3:738-743.
78. Van Vugt-Lussenbrg B.M., et al. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. J. Med. Chem. 2007, 50:455-461.
79. Otey C.R., et al. Preparation of human metabolites of propanolol using laboratory-evolved bacterial cytochromes P450. Biotechnol. Bioeng. 2006, 93:494-499.
80. Sawayama A.M., et al. A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. Chemistry 2009, 15:11723-11729.
81. Sakaki T., Munetsuna E. Enzyme systems for biodegradation of polychlorinated dibenzo-p-dioxins. Appl. Microbiol. Biotechnol. 2010, 88:23-30.
82. Alonso-Gutiérrez J., et al. Alkane-degrading properties of Dietzia sp. H0B, a key player in the Prestige oil spill biodegradation (NW Spain). J. Appl. Microbiol. 2011, 111:800-810.
83. Ghosh D., et al. Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 2009, 457:219-223.
84. McLean K.J., et al. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. Microbiology 2002, 148:2937-2949.
85. Ahmad Z., et al. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis. FEMS Microbiol. Lett. 2006, 261:181-186.
86. McLean K.J., et al. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. J. Biol. Chem. 2008, 283:33406-33416.
87. McLean K.J., et al. The structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection. J. Biol. Chem. 2009, 284:35524-35533.
88. Belin P., et al. Identification and structural basis of the reaction catalysed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7426-7431.
89. Hudson S.A., et al. Application of fragment screening and merging to the discovery of inhibitors of the Mycobacterium tuberculosis cytochrome P450 CYP121. Angew. Chem. Int. Ed. 2012, 51:9311-9316.
90. Melo N.R., et al. CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibility. Antimicrob. Agents Chemother. 2008, 52:3718-3724.
91. Jensen K., et al. Light-driven P450 hydroxylations. ACS Chem. Biol. 2011, 6:533-539.
92. van der Felt C., et al. Electron-transfer rates govern product distribution in electrochemically-driven P450-catalyzed dioxygen reduction. J. Inorg. Biochem. 2011, 105:1350-1353.
93. Faulkner K.M., et al. Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1. Proc. Natl. Acad. Sci. U.S.A. 2011, 92:7705-7709.
94. Hrycay E.G., Bandiera S.M. The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450. Arch. Biochem. Biophys. 2012, 522:71-89.
95. Akhtar M., et al. Mechanistic studies on aromatase and related carbon-carbon bond cleaving P450 enzymes. J. Steroid Biochem. Mol. Biol. 1993, 44:375-387.
96. Ortiz de Montellano P.R., De Voss J.J. Substrate oxidation by cytochrome P450 enzymes. Cytochrome P450: Structure, Mechanism and Biochemistry 2005, 183-245. Kluwer Academic. 3rd edn. P.R. Ortiz de Montellano (Ed.).
97. Woithe K., et al. Oxidative phenol coupling reactions catalyzed by OxyB: a cytochrome P450 from the vancomycin producing organism. Implications for vancomycin biosynthesis. J. Am. Chem. Soc. 2007, 129:6887-6895.
98. Sadeghi S.J., et al. Breakthrough in P450 bioelectrochemistry and future perspectives. Biochim. Biophys. Acta 2011, 1814:237-248.
99. Kumar S. Engineering cytochrome P450 biocatalysts for biotechnology. Expert Opin. Drug Metab. Toxicol. 2010, 6:115-131.
100. Hansen B., et al. Involvement of a natural fusion of a cytochrome P450 and a hydrolase in mycophenolic acid biosynthesis. Appl. Environ. Microbiol. 2012, 78:4908-4913.